-- ============================================================================
-- BATCH 8: Blood Conservation Techniques (Questions 318-367)
-- Topic: Patient blood management, alternatives to transfusion
-- ============================================================================

INSERT INTO questions (topic_id, category_id, question_text, option_a, option_b, option_c, option_d, option_e, correct_option, explanation, difficulty, cognitive_level) VALUES

-- PATIENT BLOOD MANAGEMENT PRINCIPLES
('b0000008-0000-0000-0000-000000000008', 'a0000001-0000-0000-0000-000000000001',
'Patient Blood Management (PBM) is based on three pillars:',
'Surgery, transfusion, recovery',
'Optimize red cell mass, minimize blood loss, optimize tolerance of anemia',
'Donation, storage, transfusion',
'Diagnosis, treatment, monitoring',
'Screening, surgery, rehabilitation',
'B',
'PBM three pillars: 1) Optimize patients own red cell mass (treat anemia preoperatively), 2) Minimize blood loss (surgical/pharmacological), 3) Optimize physiological tolerance of anemia.',
'medium', 'knowledge'),

('b0000008-0000-0000-0000-000000000008', 'a0000001-0000-0000-0000-000000000001',
'Preoperative anemia should be:',
'Ignored if mild',
'Identified and treated before elective surgery',
'Treated only with transfusion',
'Considered normal in elderly',
'Managed only postoperatively',
'B',
'Preoperative anemia increases morbidity/mortality and transfusion need. Screen 4-6 weeks before surgery. Investigate cause and treat (iron, B12, folate, EPO if indicated).',
'medium', 'application'),

('b0000008-0000-0000-0000-000000000008', 'a0000001-0000-0000-0000-000000000001',
'The most common cause of preoperative anemia is:',
'Chronic disease',
'Iron deficiency',
'Vitamin B12 deficiency',
'Hemolysis',
'Bone marrow suppression',
'B',
'Iron deficiency is the most common cause of preoperative anemia (blood loss, poor intake, malabsorption). Screen with ferritin, transferrin saturation. Treat with oral or IV iron.',
'medium', 'knowledge'),

-- PREOPERATIVE OPTIMIZATION
('b0000008-0000-0000-0000-000000000008', 'a0000001-0000-0000-0000-000000000001',
'IV iron is preferred over oral iron when:',
'Cost is not a concern',
'Surgery is within 2-4 weeks, intolerance to oral iron, or malabsorption',
'Patient prefers injections',
'Hemoglobin is normal',
'Iron stores are adequate',
'B',
'IV iron: Faster response (2-4 weeks vs 6-8 weeks oral), bypasses GI absorption. Use when surgery is soon, oral iron intolerance/failure, inflammatory bowel disease, malabsorption.',
'medium', 'application'),

('b0000008-0000-0000-0000-000000000008', 'a0000001-0000-0000-0000-000000000001',
'Erythropoietin (EPO) in surgical patients:',
'Replaces transfusion in all cases',
'Can be used to boost red cell mass before surgery in selected patients',
'Is contraindicated before surgery',
'Works within 24 hours',
'Is first-line treatment for acute anemia',
'B',
'EPO stimulates erythropoiesis (takes 2-4 weeks for effect). Used in: Jehovahs Witness, chronic kidney disease, autologous donation enhancement. Not for acute anemia.',
'medium', 'knowledge'),

('b0000008-0000-0000-0000-000000000008', 'a0000001-0000-0000-0000-000000000001',
'Antiplatelet medications should be discontinued before surgery:',
'On the day of surgery',
'5-10 days before surgery depending on the drug',
'Only for cardiac surgery',
'Never - continue all medications',
'1 day before surgery',
'B',
'Aspirin: 5-7 days. Clopidogrel: 5-7 days. Ticagrelor: 3-5 days. Balance bleeding risk vs thrombotic risk (especially cardiac stents). May continue aspirin for some procedures.',
'medium', 'knowledge'),

('b0000008-0000-0000-0000-000000000008', 'a0000001-0000-0000-0000-000000000001',
'Warfarin should be stopped before surgery:',
'1 day before',
'5 days before with bridging if high thrombotic risk',
'Never for any surgery',
'10 days before',
'On the morning of surgery',
'B',
'Stop warfarin 5 days before surgery (INR normalizes). Bridge with LMWH/heparin if high thrombotic risk (mechanical valve, recent VTE). Check INR on day of surgery.',
'medium', 'application'),

('b0000008-0000-0000-0000-000000000008', 'a0000001-0000-0000-0000-000000000001',
'Direct oral anticoagulants (DOACs) should be held before surgery for:',
'1-2 days for normal renal function procedures with low bleeding risk',
'7 days for all procedures',
'No need to stop',
'10 days before surgery',
'Only for cardiac surgery',
'A',
'DOACs (rivaroxaban, apixaban, dabigatran): Hold 1-2 days (low bleeding risk) to 2-4 days (high bleeding risk). Adjust for renal function. No bridging usually needed.',
'medium', 'knowledge'),

-- INTRAOPERATIVE BLOOD CONSERVATION
('b0000008-0000-0000-0000-000000000008', 'a0000001-0000-0000-0000-000000000001',
'Tranexamic acid (TXA) works by:',
'Stimulating red cell production',
'Inhibiting fibrinolysis',
'Activating platelets',
'Binding iron',
'Increasing clotting factor synthesis',
'B',
'Tranexamic acid is an antifibrinolytic - inhibits plasminogen activation, preventing clot breakdown. Reduces surgical blood loss and transfusion by 30%. Use in trauma, cardiac, orthopedic surgery.',
'medium', 'knowledge'),

('b0000008-0000-0000-0000-000000000008', 'a0000001-0000-0000-0000-000000000001',
'The CRASH-2 trial demonstrated that tranexamic acid in trauma:',
'Increases mortality',
'Reduces mortality when given within 3 hours of injury',
'Has no effect on mortality',
'Should only be used after 6 hours',
'Increases transfusion requirements',
'B',
'CRASH-2: TXA reduced all-cause mortality in bleeding trauma patients when given within 3 hours (1g bolus + 1g over 8 hours). Increased mortality if given after 3 hours.',
'medium', 'knowledge'),

('b0000008-0000-0000-0000-000000000008', 'a0000001-0000-0000-0000-000000000001',
'Cell salvage (intraoperative blood recovery) involves:',
'Transfusing donated blood',
'Collecting, washing, and reinfusing patients own shed blood',
'Collecting blood from the operative field without processing',
'Using synthetic blood substitutes',
'Preoperative blood donation',
'B',
'Cell salvage: Blood from operative field is suctioned, anticoagulated, washed, concentrated, and reinfused. Reduces allogeneic transfusion. Acceptable to some Jehovahs Witnesses.',
'medium', 'knowledge'),

('b0000008-0000-0000-0000-000000000008', 'a0000001-0000-0000-0000-000000000001',
'Contraindications to cell salvage include:',
'Cardiac surgery',
'Malignancy and bacterial contamination of field',
'Orthopedic surgery',
'Trauma surgery',
'All Jehovahs Witness patients',
'B',
'Absolute contraindications: Malignant cells in field, bacterial/fecal contamination. Relative: Amniotic fluid, topical hemostatic agents. Leukocyte depletion filters may reduce risks.',
'medium', 'knowledge'),

('b0000008-0000-0000-0000-000000000008', 'a0000001-0000-0000-0000-000000000001',
'Acute normovolemic hemodilution (ANH) is performed by:',
'Transfusing blood before surgery',
'Removing blood at surgery start, replacing with crystalloid, reinfusing blood at end',
'Cell salvage during surgery',
'Preoperative blood donation weeks before',
'Using blood substitutes',
'B',
'ANH: 1-3 units removed at anesthesia induction, replaced with crystalloid/colloid (3:1 or 1:1). Blood loss during surgery is dilute. Autologous blood reinfused at case end.',
'medium', 'knowledge'),

('b0000008-0000-0000-0000-000000000008', 'a0000001-0000-0000-0000-000000000001',
'The benefit of ANH is that:',
'Blood lost during surgery has lower hematocrit, so less RBCs are lost',
'It increases surgical blood loss',
'It eliminates need for cross-match',
'It works for all patients',
'It provides better oxygen delivery',
'A',
'With ANH, blood lost during surgery is hemodiluted (lower Hct), so fewer RBCs are lost. The removed whole blood (with normal Hct, functioning platelets, clotting factors) is reinfused at end.',
'medium', 'comprehension'),

-- SURGICAL TECHNIQUES
('b0000008-0000-0000-0000-000000000008', 'a0000001-0000-0000-0000-000000000001',
'Meticulous surgical technique to minimize blood loss includes:',
'Faster surgery regardless of hemostasis',
'Careful hemostasis, proper patient positioning, avoid hypothermia',
'Using larger incisions',
'Avoiding electrocautery',
'Operating without any devices',
'B',
'Minimize blood loss: Good hemostasis (electrocautery, clips, sutures), proper positioning (reduce venous congestion), normothermia (coagulation optimal at 37°C), minimize operative time.',
'medium', 'application'),

('b0000008-0000-0000-0000-000000000008', 'a0000001-0000-0000-0000-000000000001',
'Controlled hypotension during surgery:',
'Is contraindicated in all cases',
'Reduces blood loss by lowering MAP to 50-65 mmHg in selected cases',
'Increases blood loss',
'Is only used in cardiac surgery',
'Should reduce MAP below 40 mmHg',
'B',
'Deliberate hypotension (MAP 50-65 mmHg) reduces bleeding in selected surgeries (spine, major joint). Contraindicated: Cerebrovascular disease, coronary disease, kidney disease.',
'hard', 'knowledge'),

('b0000008-0000-0000-0000-000000000008', 'a0000001-0000-0000-0000-000000000001',
'Topical hemostatic agents work by:',
'Stimulating systemic coagulation',
'Providing local matrix for clot formation or vasoconstriction',
'Replacing platelets',
'Dissolving existing clots',
'Increasing blood flow',
'B',
'Topical hemostatics: Gelatin sponge (matrix), oxidized cellulose (matrix, bactericidal), thrombin (activates fibrinogen), fibrin sealant (fibrin clot), tranexamic acid (antifibrinolytic).',
'medium', 'knowledge'),

('b0000008-0000-0000-0000-000000000008', 'a0000001-0000-0000-0000-000000000001',
'Tourniquets in limb surgery:',
'Should never be used',
'Create bloodless field but should be used for limited time (<2 hours)',
'Can be used indefinitely',
'Increase blood loss',
'Are only for trauma',
'B',
'Tourniquets provide bloodless surgical field. Limit inflation time (<2 hours) to prevent ischemic injury. Release periodically for very long procedures. Post-release bleeding expected.',
'medium', 'knowledge'),

-- PHARMACOLOGICAL AGENTS
('b0000008-0000-0000-0000-000000000008', 'a0000001-0000-0000-0000-000000000001',
'Epsilon-aminocaproic acid (EACA) and tranexamic acid are both:',
'Procoagulants',
'Antifibrinolytics',
'Anticoagulants',
'Platelet stimulants',
'Iron supplements',
'B',
'Both are lysine analogues that inhibit fibrinolysis by blocking plasminogen binding to fibrin. TXA is 10× more potent than EACA. Both reduce surgical blood loss.',
'medium', 'knowledge'),

('b0000008-0000-0000-0000-000000000008', 'a0000001-0000-0000-0000-000000000001',
'Desmopressin (DDAVP) reduces bleeding by:',
'Inhibiting fibrinolysis',
'Releasing von Willebrand factor and Factor VIII from endothelium',
'Stimulating platelet production',
'Activating vitamin K',
'Providing fibrinogen',
'B',
'DDAVP stimulates release of vWF and Factor VIII from endothelial stores. Used for: Mild hemophilia A, von Willebrand disease, uremic bleeding, platelet dysfunction.',
'medium', 'knowledge'),

('b0000008-0000-0000-0000-000000000008', 'a0000001-0000-0000-0000-000000000001',
'Vitamin K is used to reverse:',
'Heparin',
'Warfarin and vitamin K deficiency coagulopathy',
'Direct thrombin inhibitors',
'Platelet dysfunction',
'Tranexamic acid',
'B',
'Vitamin K reverses warfarin and treats vitamin K deficiency (liver disease, malabsorption, antibiotics). Takes 6-24 hours for effect. Use FFP/PCC for urgent reversal.',
'easy', 'knowledge'),

('b0000008-0000-0000-0000-000000000008', 'a0000001-0000-0000-0000-000000000001',
'Prothrombin Complex Concentrate (PCC) is used for:',
'Iron deficiency',
'Urgent reversal of warfarin',
'Heparin reversal',
'Platelet transfusion',
'Treatment of hemophilia B only',
'B',
'PCC contains Factors II, VII, IX, X (± proteins C and S). Rapid, complete warfarin reversal with small volume. Also for factor deficiencies, DOAC reversal (4-factor PCC).',
'medium', 'knowledge'),

('b0000008-0000-0000-0000-000000000008', 'a0000001-0000-0000-0000-000000000001',
'Protamine sulfate is the specific antidote for:',
'Warfarin',
'Unfractionated heparin',
'Dabigatran',
'Aspirin',
'Tranexamic acid',
'B',
'Protamine: positively charged, binds negatively charged heparin. 1mg protamine neutralizes ~100 units UFH. Partially reverses LMWH (~60%). Risk of hypotension, anaphylaxis.',
'easy', 'knowledge'),

('b0000008-0000-0000-0000-000000000008', 'a0000001-0000-0000-0000-000000000001',
'Idarucizumab (Praxbind) is the reversal agent for:',
'Rivaroxaban',
'Dabigatran',
'Apixaban',
'Warfarin',
'Heparin',
'B',
'Idarucizumab is a monoclonal antibody fragment that binds dabigatran (direct thrombin inhibitor). Complete reversal within minutes. Andexanet alfa reverses factor Xa inhibitors.',
'medium', 'knowledge'),

-- TOLERANCE OF ANEMIA
('b0000008-0000-0000-0000-000000000008', 'a0000001-0000-0000-0000-000000000001',
'Physiological compensation for acute anemia includes:',
'Decreased cardiac output',
'Increased cardiac output and oxygen extraction',
'Decreased oxygen extraction',
'Vasoconstriction',
'Decreased 2,3-DPG',
'B',
'Compensation: Increased cardiac output (HR and stroke volume), increased O2 extraction, rightward shift of O2-Hb dissociation (increased 2,3-DPG), redistribution of blood flow.',
'medium', 'knowledge'),

('b0000008-0000-0000-0000-000000000008', 'a0000001-0000-0000-0000-000000000001',
'The critical hemoglobin level below which oxygen delivery becomes inadequate is approximately:',
'10-11 g/dL',
'8-9 g/dL',
'5-7 g/dL in healthy individuals',
'12 g/dL',
'3 g/dL',
'C',
'Healthy euvolemic patients can tolerate Hb 5-7 g/dL (some lower). Critical level depends on cardiovascular reserve. CAD patients need higher Hb (8-10 g/dL) for adequate myocardial O2.',
'hard', 'knowledge'),

('b0000008-0000-0000-0000-000000000008', 'a0000001-0000-0000-0000-000000000001',
'Supplemental oxygen therapy in anemic patients:',
'Is not helpful as Hb is reduced',
'Increases dissolved O2 and may slightly improve oxygen delivery',
'Causes oxygen toxicity at all levels',
'Decreases oxygen extraction',
'Is contraindicated',
'B',
'While Hb-bound O2 is limited, supplemental O2 increases dissolved O2 (small but helpful) and ensures full Hb saturation. Not a substitute for transfusion in severe anemia.',
'medium', 'comprehension'),

('b0000008-0000-0000-0000-000000000008', 'a0000001-0000-0000-0000-000000000001',
'Maintaining normovolemia in anemic patients is important because:',
'Hypovolemia is easily tolerated',
'Adequate preload maintains cardiac output for oxygen delivery',
'It prevents hypothermia',
'It is not important',
'It reduces oxygen consumption',
'B',
'Normovolemia maintains cardiac preload → adequate cardiac output → oxygen delivery despite low Hb. Hypovolemia compromises compensation and increases mortality.',
'medium', 'comprehension'),

-- BLOOD SUBSTITUTES AND ALTERNATIVES
('b0000008-0000-0000-0000-000000000008', 'a0000001-0000-0000-0000-000000000001',
'Hemoglobin-based oxygen carriers (HBOCs) are:',
'Currently widely used clinically',
'Experimental oxygen-carrying blood substitutes',
'Derived from donated plasma',
'Made from platelets',
'Used for volume expansion only',
'B',
'HBOCs are cell-free hemoglobin solutions (bovine or recombinant). Promise: no cross-match, long shelf life, no infection risk. Problems: vasoconstriction, oxidative stress. Still experimental.',
'medium', 'knowledge'),

('b0000008-0000-0000-0000-000000000008', 'a0000001-0000-0000-0000-000000000001',
'Perfluorocarbon emulsions for oxygen carriage:',
'Bind oxygen like hemoglobin',
'Dissolve oxygen and CO2 (require high FiO2)',
'Are currently standard of care',
'Are derived from blood',
'Stimulate erythropoiesis',
'B',
'PFCs dissolve gases (O2, CO2) - dont bind. Require high FiO2 (60-100%) to work. Cleared rapidly from circulation. Limited current clinical use.',
'hard', 'knowledge'),

-- JEHOVAHS WITNESS PATIENTS
('b0000008-0000-0000-0000-000000000008', 'a0000001-0000-0000-0000-000000000001',
'Jehovahs Witness patients who refuse blood transfusion:',
'Cannot undergo any surgery',
'May accept cell salvage, ANH, EPO, and other blood conservation techniques',
'Must accept all blood products in emergencies',
'Can only have minor procedures',
'Always refuse all interventions',
'B',
'Many JW accept: Cell salvage (if continuous circuit), ANH, EPO, iron, clotting factors, albumin, own stored blood connected to circulation. Individual variation - discuss preoperatively.',
'medium', 'knowledge'),

('b0000008-0000-0000-0000-000000000008', 'a0000001-0000-0000-0000-000000000001',
'Legal considerations for refusing transfusion include:',
'Transfusion can be forced in all cases',
'Competent adults can refuse even life-saving treatment',
'Refusal is never legally valid',
'Courts always override patient wishes',
'Only written refusal is valid',
'B',
'Competent adults have the right to refuse treatment. Document refusal clearly. Court order may be sought for minors. Advance directive should be honored. Discuss alternatives.',
'medium', 'knowledge'),

-- POSTOPERATIVE CARE
('b0000008-0000-0000-0000-000000000008', 'a0000001-0000-0000-0000-000000000001',
'Restrictive transfusion strategy postoperatively means:',
'No transfusion for any patient',
'Transfusing at lower Hb thresholds (7-8 g/dL) in stable patients',
'Transfusing liberally to Hb 12 g/dL',
'Automatic transfusion for all surgical patients',
'Using only autologous blood',
'B',
'Restrictive strategy: Transfuse at Hb 7-8 g/dL in stable patients. Multiple trials show equivalent or better outcomes vs liberal (Hb 9-10 g/dL). Exceptions: ACS, symptomatic anemia.',
'medium', 'knowledge'),

('b0000008-0000-0000-0000-000000000008', 'a0000001-0000-0000-0000-000000000001',
'Single-unit transfusion policy refers to:',
'Giving only one type of blood product',
'Transfusing one unit then reassessing before additional units',
'Always giving two units',
'Never transfusing',
'Emergency transfusion protocol',
'B',
'One-unit policy: Transfuse one unit, reassess symptoms and Hb, decide on need for more. Reduces unnecessary transfusion. Exception: Active massive hemorrhage.',
'medium', 'knowledge'),

('b0000008-0000-0000-0000-000000000008', 'a0000001-0000-0000-0000-000000000001',
'Postoperative iron supplementation:',
'Is contraindicated after surgery',
'Can aid recovery from postoperative anemia',
'Is only given intravenously',
'Has no effect on hemoglobin',
'Should be given before diagnosis',
'B',
'Postoperative iron (oral or IV) helps rebuild iron stores and support erythropoiesis. Oral iron may be poorly absorbed after major surgery; IV iron provides faster repletion.',
'medium', 'application'),

('b0000008-0000-0000-0000-000000000008', 'a0000001-0000-0000-0000-000000000001',
'Point-of-care coagulation testing (TEG/ROTEM) allows:',
'Only platelet counting',
'Goal-directed hemostatic therapy based on real-time results',
'Replacement of laboratory testing entirely',
'Blood typing at bedside',
'Only fibrinogen measurement',
'B',
'TEG/ROTEM provide real-time viscoelastic assessment of clot formation and lysis. Guides targeted therapy (FFP, platelets, cryo, TXA) rather than empiric treatment. Reduces transfusion.',
'medium', 'knowledge'),

('b0000008-0000-0000-0000-000000000008', 'a0000001-0000-0000-0000-000000000001',
'The goal of patient blood management programs is to:',
'Increase blood usage',
'Improve patient outcomes while reducing unnecessary transfusion',
'Eliminate all transfusions',
'Reduce hospital costs only',
'Train blood bank staff',
'B',
'PBM aims to optimize patient care by: Treating anemia preoperatively, minimizing blood loss, tolerating anemia when safe. Improves outcomes, reduces complications, is cost-effective.',
'easy', 'knowledge');
